VANCOUVER, Oct. 21 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced
today that during the past few months it has trained over 100
Gastroenterologists as part of its strategic initiative to sell the Company's
patented proprietary hemorrhoid banding technology directly to physicians. The
Company believes this distribution approach complements its core strategy of
operating Centers for Colorectal Health where the CRH technology is
administered. The Company currently operates 17 such Centers across the United
States.
